Treatment Information

Back

Ovarian Cancer treatment details. Chemotherapy.

National Cancer Institute, Bethesda, MD, United States.

Survival: monthsCountry:United States
Toxiciy Grade:4City/State/Province:Bethesda, MD
Treatments:ChemotherapyHospital:National Cancer Institute
Drugs:Journal:Link
Date:May 2005

Description:

Patients: This phase I study involved 26 patients with advanced solid tissue cancers, including colorectal (6), ovarian (4), and breast (4). All patients had received treatment before the study, and twenty of the patients were 50 years of age or older.

Treatment: The treatment involved one chemotherapeutic agent: ixabepilone.

Toxicity: Grade 3-4 toxicities included: neutropenia, thrombocytopenia, and fatigue.

Results: No overall survival was determined. One patient with ovarian carcinoma had stable disease for 14 months.

Correspondence: Tito Fojo, M.D., Ph.D.





Back